Day: November 13
The Business of Personalized Medicine: Developing Viable Commercial Strategies for Personalized Medicine Companies
Industry innovation in diagnostic technologies and targeted treatment strategies drives progress in personalized medicine. But the path to market is fraught with obstacles. Pioneering investors and executives reflect on how to deal with challenges and uncertainty in an increasingly variable development and market environment. MODERATOR | Kristin Ciriello Pothier, Life Sciences Sector Leader, Global Deal Advisory […]
Networking Break
Sponsored by:
Beyond Gene Testing: Next Generation Personalized Medicine Diagnostic Technologies in Clinical Practice (Proteomics, Metagenomics, and Digital Tools)
This session explores the cutting edge of personalized medicine beyond traditional gene testing, highlighting the clinical integration of next-generation diagnostic technologies. Experts will discuss the promise and practical application of proteomics, metagenomics, and digital diagnostic tools in delivering more precise, timely, and individualized care.. MODERATOR | Thomas Slavin, M.D., Chief Clinical Officer, Molecular Oncology & […]
The Past, Present, and Future of Innovation in Personalized Medicine: A Fireside Chat with Peter Marks, M.D., Ph.D.
MODERATOR | Lauren Silvis, J.D., Senior Vice President, External Affairs, Tempus AI, Inc. KEYNOTE SPEAKER | Peter Marks, M.D., Ph.D., Senior Vice President & Head, Infectious Diseases & Molecule Discovery, Eli Lilly; Former Director, Center for Biologics Evaluation & Research, U.S. Food & Drug Administration
Opening Remarks
SPEAKER | Daryl Pritchard, Ph.D., President, Personalized Medicine Coalition
